tiprankstipranks
Trending News
More News >
AbbVie (ABBV)
NYSE:ABBV
US Market
Advertisement

AbbVie (ABBV) Technical Analysis

Compare
23,083 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
6Neutral
1Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
AbbVie’s (ABBV) Moving Averages Convergence Divergence (MACD) indicator is 4.34, suggesting AbbVie is a Buy.
AbbVie’s (ABBV) 20-Day exponential moving average is 217.23, while AbbVie’s (ABBV) share price is $223.16, making it a Buy.
AbbVie’s (ABBV) 50-Day exponential moving average is 208.88, while AbbVie’s (ABBV) share price is $223.16, making it a Buy.

AbbVie (ABBV) Pivot Points

Sep 30, 2025, 10:40 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
214.55
216.11
218.36
219.92
222.17
223.73
225.98
Fibonacci
216.11
217.57
218.46
219.92
221.38
222.27
223.73
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

AbbVie (ABBV) Moving Averages

Sep 30, 2025, 10:40 PM
Period
Simple
Exponential
MA5
220.98Buy
221.28Buy
MA10
220.90Buy
220.22Buy
MA20
217.32Buy
217.23Buy
MA50
206.53Buy
208.88Buy
MA100
196.15Buy
201.13Buy
MA200
191.01Buy
193.88Buy
AbbVie’s (ABBV) 10-Day exponential moving average is 220.22, while AbbVie’s (ABBV) share price is $223.16, making it a Buy.
AbbVie’s (ABBV) 100-Day exponential moving average is 201.13, while AbbVie’s (ABBV) share price is $223.16, making it a Buy.
AbbVie’s (ABBV) stock price is $223.16 and AbbVie’s (ABBV) 50-day simple moving average is 206.53, creating a Buy signal.
AbbVie’s (ABBV) stock price is $223.16 and AbbVie’s (ABBV) 100-day simple moving average is 196.15, creating a Buy signal.
AbbVie’s (ABBV) stock price is $223.16 and AbbVie’s (ABBV) 200-day simple moving average is 191.01, creating a Buy signal.

AbbVie (ABBV) Technical Indicators

Sep 30, 2025, 10:40 PM
Name
Value
Implied Action
RSI (14)
67.97
Neutral
STOCH (9,6)
54.91
Neutral
STOCHRSI (14)
74.37
Neutral
MACD (12,26)
4.34
Buy
ADX (14)
34.94
Neutral
Williams %R
-11.96
Sell
CCI (14)
79.08
Neutral
ATR (14)
3.65
-
Ultimate Oscillator
51.84
Neutral
ROC
6.05
Buy
AbbVie’s (ABBV) Relative Strength Index (RSI) is 67.97, creating a Neutral signal.
AbbVie’s (ABBV) Trend Strength Indicator (ADX) is 34.94, creating a Neutral signal.
AbbVie’s (ABBV) Commodity Channel Index (CCI) is 79.08, creating a Neutral signal.
AbbVie’s (ABBV) Price Rate of Change (ROC) is 6.05, creating a Buy signal.

FAQ

Is ABBV a Buy, Hold, or Sell?
Based on ABBV’s technical indicators, ABBV is a Strong Buy.
    What is ABBV’s RSI (14)?
    ABBV’s RSI (14) is 67.97, which suggests ABBV is a Neutral.
      What is ABBV’s MACD?
      ABBV’s MACD is 4.34, which suggests ABBV is a Buy.
        What is ABBV’s 5-day moving average?
        ABBV’s 5-day moving average is 220.98, which suggests ABBV is a Buy.
          What is ABBV’s 20-day moving average?
          ABBV 20-day moving average is 217.32, which suggests ABBV is a Buy.
            What is ABBV’s 50-day moving average?
            ABBV’s 50-day moving average is 206.53, which suggests ABBV is a Buy.
              What is ABBV’s 200-day moving average?
              ABBV’s 200-day moving average is 191.01, which suggests ABBV is a Buy.
                What is ABBV’s Williams % R (14)?
                ABBV’s Williams % R (14) is -11.96, which suggests ABBV is a Sell.
                  What is ABBV’s CCI (14)?
                  ABBV’s CCI (14) is 79.08, which suggests ABBV is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis